Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Sharavan Ramachandran"'
Publikováno v:
Molecular Therapy: Oncolytics, Vol 19, Iss , Pp 19-32 (2020)
Despite major advances in cancer treatment, pancreatic cancer is still incurable and the treatment outcomes are limited. The aggressive and therapy-resistant nature of pancreatic cancer warrants the need for novel treatment options for pancreatic can
Externí odkaz:
https://doaj.org/article/e9929c6e37a04d749550bbf99599f9c0
Autor:
Alok Ranjan, Sharavan Ramachandran, Nehal Gupta, Itishree Kaushik, Stephen Wright, Suyash Srivastava, Hiranmoy Das, Sangeeta Srivastava, Sahdeo Prasad, Sanjay K. Srivastava
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 20, p 4981 (2019)
The use of synthetic, natural, or biological agents to minimize the occurrence of cancer in healthy individuals is defined as cancer chemoprevention. Chemopreventive agents inhibit the development of cancer either by impeding DNA damage, which leads
Externí odkaz:
https://doaj.org/article/01b6aeed952c4d5da7692f885e06abf1
Publikováno v:
Proceedings, Vol 1, Iss 10, p 981 (2017)
Malignant melanoma is significant problem for Caucasian population in the western countries. Mutations in BRAF gene in 60% of patients is responsible for developing resistance to BRAF inhibitors. Our results delineated the mechanism of resistance and
Externí odkaz:
https://doaj.org/article/4573bed945e34af9aff55aff89567da0
Publikováno v:
Seminars in Cancer Biology. 86:491-498
Immune check point inhibitors (ICIs) have marked their existence in the field of cancer immunotherapy. Their existence dates to 2011 when the first anti-cytotoxic T lymphocyte-associated protein 4 (CTLA-4) got its FDA approval for the management of m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62277f044b0e34f8be8540b3022bf6d7
https://doi.org/10.1016/j.semcancer.2022.03.020
https://doi.org/10.1016/j.semcancer.2022.03.020
Publikováno v:
Cancer Research. 83:4873-4873
Glioblastoma multiforme (GBM) is a highly aggressive grade IV malignant brain tumor with an average survival time of around 15 months; and a 5-year survival rate of 5%. Drug resistance, blood brain barrier (BBB) impermeability, and drug toxicity are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d1aca6b643ec3bd972d0860b73cc658
https://doi.org/10.1158/1538-7445.am2023-4873
https://doi.org/10.1158/1538-7445.am2023-4873
Publikováno v:
Semin Cancer Biol
Cancer continues to be one of the leading contributors towards global disease burden. According to NIH, cancer incidence rate per year will increase to 23.6 million by 2030. Even though cancer continues to be a major proportion of the disease burden
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::594973e54596f0c5f1ca6ab3326d0b34
https://doi.org/10.1016/j.semcancer.2020.03.011
https://doi.org/10.1016/j.semcancer.2020.03.011
Publikováno v:
Molecular Therapy Oncolytics
Molecular Therapy: Oncolytics, Vol 19, Iss, Pp 19-32 (2020)
Molecular Therapy: Oncolytics, Vol 19, Iss, Pp 19-32 (2020)
Despite major advances in cancer treatment, pancreatic cancer is still incurable and the treatment outcomes are limited. The aggressive and therapy-resistant nature of pancreatic cancer warrants the need for novel treatment options for pancreatic can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a6992608b8cd5dc085cbdc25a7b3287
https://doi.org/10.1016/j.omto.2020.08.019
https://doi.org/10.1016/j.omto.2020.08.019
Publikováno v:
Journal of Academic Ethics. 18:143-153
Music plagiarism is defined as using tune, or melody that would closely imitate with another author’s music without proper attributions. It may occur either by stealing a musical idea (a melody or motif) or sampling (a portion of one sound, or tune
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb31f7350c60686b6b068424e25ef8f6
https://doi.org/10.1007/s10805-020-09360-7
https://doi.org/10.1007/s10805-020-09360-7
Publikováno v:
Journal of Biological Chemistry. 299:104332
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5cd9fbf5849fc459703e2609e6488ccd
https://doi.org/10.1016/j.jbc.2023.104332
https://doi.org/10.1016/j.jbc.2023.104332
Publikováno v:
Semin Cell Dev Biol
CRISPR-Cas9 is an RNA guided endonuclease that has revolutionized the ability to edit genome and introduce desired manipulations in the target genomic sequence. It is a flexible methodology and is capable of targeting multiple loci simultaneously. Ow
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cb0936b921762d86089fb069cd466a7
https://doi.org/10.1016/j.semcdb.2019.04.018
https://doi.org/10.1016/j.semcdb.2019.04.018